E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/31/2018 in the Prospect News Structured Products Daily.

New Issue: Credit Suisse sells $1.97 million 9% contingent coupon autocalls on three funds

By Susanna Moon

Chicago, May 31 – Credit Suisse AG, London branch priced $1.97 million of contingent coupon autocallable yield notes due Feb. 28, 2020 linked to the worst performing of the SPDR S&P Biotech Trust, the Financial Select Sector SPDR Fund and the iShares MSCI Emerging Markets ETF, according to a 424B2 filing with the Securities and Exchange Commission.

The notes will pay a contingent quarterly coupon at an annual rate of 9% if each underlying fund closes at or above its 60% coupon barrier on each trading day for that quarter.

The notes are called at par if each fund closes at or above its initial level on any determination date other than the final date.

The payout at maturity will be par unless any underlying fund finishes below its 60% knock-in level, in which case investors will be fully exposed to any losses of the worst performing fund.

Credit Suisse Securities (USA) LLC is the agent.

Issuer:Credit Suisse AG, London branch
Issue:Contingent coupon autocallable yield notes
Underlying assets:SPDR S&P Biotech Trust, the Financial Select Sector SPDR Fund and iShares MSCI Emerging Markets ETF
Amount:$1,965,000
Maturity:Feb. 28, 2020
Coupon:9% annualized, payable quarterly if each fund closes at or above 60% coupon barrier on each trading day for that quarter
Price:Par
Payout at maturity:If each fund finishes at or above knock-in level, par; otherwise, 1% loss for each 1% decline of worst performing fund
Call:At par if each fund closes at or above its initial level on any determination date other than final date
Initial levels:$46.49 for biotech fund, $92.44 for financial fund and $28.16 for EM fund
Knock-in levels:$27.894 for biotech fund, $55.464 for financial fund and $16.896 for EM fund, 60% of initial levels
Pricing date:May 23
Settlement date:May 29
Agent:Credit Suisse Securities (USA) LLC with Morgan Stanley Wealth Management as a distributor
Fees:0.725%
Cusip:22550WUN5

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.